n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with Memory Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, K; Ikuno, T; Izumi, H; Shinoda, Y; Shioda, N; Yabuki, Y | 1 |
| Fukunaga, K; Ikuno, T; Moriguchi, S; Yamamoto, Y | 1 |
| Hiramatsu, M; Hoshino, T; Kanematsu, K | 1 |
| Hiramatsu, M; Hoshino, T | 1 |
| Altar, CA; Kikuchi, T; Miwa, T; Nakai, M; Oshiro, Y; Tottori, K; Uwahodo, Y; Yamada, S | 1 |
5 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and Memory Disorders
| Article | Year |
|---|---|
Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation.
Topics: Adenosine Triphosphate; Animals; Anisoles; Brain Ischemia; CA1 Region, Hippocampal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carotid Artery Diseases; Cell Death; Dehydroepiandrosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Male; Memory Disorders; Mice, Inbred C57BL; Narcotic Antagonists; Neurons; Neuroprotective Agents; Nootropic Agents; Propylamines; Proto-Oncogene Proteins c-akt; Receptors, sigma; Sigma-1 Receptor | 2015 |
Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
Topics: Animals; Anisoles; Avoidance Learning; Behavior, Animal; Blotting, Western; CA1 Region, Hippocampal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cognition Disorders; Dehydroepiandrosterone; Electrophysiological Phenomena; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Olfactory Bulb; Phosphorylation; Propylamines; Protein Kinase C; Psychomotor Performance; Receptors, sigma; Recognition, Psychology; Sigma-1 Receptor | 2011 |
Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Topics: Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Morphine Derivatives; Narcotic Antagonists; Pain; Pain Measurement; Propylamines; Receptors, Opioid; Scopolamine; Statistics, Nonparametric | 2005 |
Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Topics: Acetic Acid; Analgesics, Opioid; Analysis of Variance; Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Isomerism; Male; Maze Learning; Memory Disorders; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Pentazocine; Propylamines; Receptors, Opioid, kappa; Receptors, sigma; Scopolamine | 2005 |
Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Anisoles; Avoidance Learning; Brain Chemistry; Cholinergic Agents; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Male; Maze Learning; Memory Disorders; Microdialysis; Muscarinic Antagonists; Piperazines; Propylamines; Quinolones; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, sigma; Scopolamine; Serotonin Receptor Agonists | 2002 |